CDIO
Cardio Diagnostics Holdings, Inc.
There isn't enough reported data to score CDIO yet.
CDIO Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
CDIO's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
CDIO PE Valuation
CDIO has no meaningful PE right now: it lost money over the past year.
CDIO Forward outlook
There aren't enough analyst estimates for CDIO to show an outlook.
CDIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$9.60 | +$53.50 |
| Q2 2024 | -$12.60 | +$45.06 |
| Q1 2024 | -$22.50 | +$25.28 |
| Q4 2023 | -$19.80 | +$25.50 |
| Q3 2023 | -$63.10 | -$61.08 |
| Q2 2023 | -$57.66 | -$55.00 |
| Q1 2023 | -$47.78 | -$46.93 |
| Q4 2022 | -$45.30 | -$45.26 |
CDIO is still losing money, but far less than before: $2.52 per share over the past year, against $63.10 at its worst in late 2023.
CDIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.6K | +26% |
| Q2 2026 | $5.4K | -28% |
| Q1 2026 | $2.7K | +185% |
| Q4 2025 | $3.6K | -21% |
| Q3 2025 | $2.9K | -57% |
| Q2 2025 | $7.5K | -5% |
| Q1 2025 | $940 | -94% |
| Q4 2024 | $4.5K | -15% |
CDIO's revenue is recovering but still below its 2024 peak: $3,590 last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -48194% | +11757 points |
| Q2 2026 | -27951% | -5493 points |
| Q1 2026 | -66598% | +106865 points |
| Q4 2025 | -41160% | -7551 points |
| Q3 2025 | -59951% | -38538 points |
| Q2 2025 | -22458% | -6162 points |
| Q1 2025 | -173464% | -147359 points |
| Q4 2024 | -33608% | -4569 points |
CDIO's operating margin was −48194% last quarter, up 11757 points from the same quarter a year ago.
CDIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.5M | +$40.4K |
| Q2 2026 | -$1.3M | +$247.8K |
| Q1 2026 | -$1.6M | -$158.1K |
| Q4 2025 | -$1.4M | +$34.1K |
| Q3 2025 | -$1.6M | -$375.6K |
| Q2 2025 | -$1.6M | -$211.9K |
| Q1 2025 | -$1.4M | -$152.9K |
| Q4 2024 | -$1.4M | +$826.8K |
CDIO has burned cash in almost every quarter: −$6M over the past year, against −$6M the year before.
CDIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +70% | +1.2M shares |
| 3 years | +833% | +2.6M shares |
CDIO has 3M diluted shares, up 70% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
CDIO Net Leverage
CDIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CDIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.5 | Neutral |
| Stochastic | 26.3 | Neutral |
CDIO's weekly RSI is 48 (neutral) and its Stochastic is 26 (neutral).
CDIO PE vs Healthcare Sector
CDIO has no meaningful PE right now: it lost money over the past year.
CDIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.79 | 4.5% above |
| 20 week MA | $1.83 | 2.2% above |
| 50 week MA | $2.18 | 14% below |
| 100 week MA | $5.53 | 66% below |
| 200 week MA | $21.2 | 91% below |
CDIO has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 91% below its 200-week average.
CDIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $294.6 | $32.4 | -89% |
| 2023 | $32.4 | $74.7 | +131% |
| 2024 | $74.7 | $27.8 | -63% |
| 2025 | $27.8 | $3.33 | -88% |
| 2026 YTD | $3.33 | $1.87 | -44% |
CDIO's yearly returns have swung widely, from +131% in 2023 to −89% in 2022. It's down 44% so far in 2026.